Drug Trial Radar · NCT07082920
A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer
Last checked: Nov 19, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
140
Planned (sponsor's estimate)
Start
Jul 7, 2025
Primary completion
Nov 30, 2027
Study completion Dec 30, 2027
Sponsor
- Lead sponsor
- Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
- Sponsor type
- Industry
- First posted
- Jul 24, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to identify the recommended phase 2 combination dose (RP2CD) of JNJ-78278343 in combination with JNJ-95298177 in Part 1 (Dose confirmation) of the study and to determine how safe and tolerable the RP2CD of JNJ-7827834 and JNJ-95298177 with or without JNJ-87189401 is for treatment of participants with metastatic castration-resistant prostate cancer (mCRPC; a stage of prostate cancer where the cancer has spread beyond the prostate and is resistant to hormonal therapy) in Part 2 (Dose expansion) of study.
Conditions
- Prostatic Neoplasms
Interventions
JNJ-78278343Drug
JNJ-78278343 will be administered intravenously.
JNJ-95298177Drug
JNJ-95298177 will be administered intravenously.
JNJ-87189401Drug
JNJ-87189401 will be administered.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Adverse Events (AEs) by SeverityTime frame: Up to 2 years 2 months
- Part 1: Number of Participants With Dose-Limiting Toxicity (DLT)Time frame: Up To Day 22
Locations
6 sites in 2 countries. Site status is shown where the registry gives one.
Florida Cancer Specialists
Sarasota, Florida · Recruiting
Columbia University Medical Center
New York, New York · Recruiting
University Hospitals Cleveland Medical Center
Cleveland, Ohio · Recruiting
Fred Hutchinson Cancer Center
Seattle, Washington · Recruiting
The Christie Nhs Foundation Trust
Manchester, United Kingdom · Recruiting
Royal Marsden Hospital (Sutton)
Sutton, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.